Mucosal Cytokine Response After Short-Term Gluten Challenge in Celiac Disease and Non-Celiac Gluten Sensitivity

Brottveit, Margit; Beitnes, Ann-Christin Røberg; Tollefsen, Stig; Bratlie, Jorunn; Jahnsen, Frode L.; Johansen, Finn–Eirik; Sollid, Ludvig M.; Lundin, Knut E.A.

doi:10.1038/ajg.2013.91

Cited by 169 publications

(146 citation statements)

References 45 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…In 2011, Sapone etal suggested an innate immune response [112] with activation of toll like receptors while other studies have suggested increased intestinal permeability to be responsible [113][114][115][116]. Increased CD3 positive IEL105,112-117 and increased interferon γ to a gluten challenge [117] suggests gut mucosal activation.…”

Section: Non-celiac Gluten Sensitivity (Ncgs)mentioning

confidence: 99%

Gluten and the Gut: A Brief Review of Gluten-Related Gastrointestinal Disorders

Shah¹

2017

SOJI

View full text Add to dashboard Cite

We conducted online electronic searches (published manuscripts in English) of the Cochrane Library, pub med and manual searches of selected specialty journals to identify any pertinent literature. The search was conducted using the key words 'celiac disease', 'gluten related disorder', 'non celiac gluten sensitivity', 'wheat allergy', 'gluten', , 'gluten free diet'. Studies not published in English or published only in the abstract form were excluded. We also conducted a focused review of available references to identify subsequent pertinent papers. AbstractCeliac disease (CD) was the first gluten-related disorder to be described. Presently the realm of gluten-related disorders also includes non-celiac gluten sensitivity (NCGS) and wheat allergy (WA). CD is a multisystem immune mediated enteropathy observed in genetically susceptible individuals exposed to dietary gluten present in barley, rye and wheat. Although the prevalence of CD is on the rise, it still largely remains under diagnosed given that many cases can be silent, subtle or atypical. The Pathophysiology of CD includes both innate and adaptive immune response to dietary gluten. Patients present with a wide variety of intestinal and extra-intestinal symptoms and are at risk for non-Hodgkin's lymphoma and small intestinal adenocarcinoma. The corner stone for treatment of CD is a gluten-free diet (GFD). NCGS is an emerging condition associated with gluten ingestion and the diagnosis of which is based on exclusion of CD and WA. Further evidence and studies are required to fully appreciate the clinical entity of NCGS and WA to detail its epidemiology and pathogenesis. The symptoms of NCGS and WA may overlap with CD and hence it is imperative to differentiate these clinical entities and select patients for appropriate management.Keywords: Celiac disease, gluten related disorder, non-celiac gluten sensitivity, wheat allergy, gluten, epidemiology, clinical features, Pathophysiology, management, gluten free diet.Core tip: CD is largely under-diagnosed while the incidence and prevalence of gluten-related disorders are on the rise. A clear understanding of the various clinical presentations of gluten-related disorders can help differentiate CD from NCGS and WA. The management for these conditions differs and hence accurate diagnosis leads to improved patient outcomes with avoidance of longterm complications as well as unnecessary testing which can be both invasive and expensive. Celiac DiseaseThe term celiac is derived from the Greek word "koiliaks" meaning "abdominal". It was first described in the second century in modern day Turkey by a Greek physician Aretaeus of Cappadocia [1]. In 1888, Samuel Gee; a pediatrician from the United Kingdom gave the first modern-day description of the condition and associated diet to the treatment of celiac disease EpidemiologyCeliac disease occurs in about 1% of the general population worldwide [7]. Data from the USA suggests CD to be more common in Caucasians as compared to African-Americans and Hispanics [8,9]. The initial ...

show abstract

Section: Non-celiac Gluten Sensitivity (Ncgs)mentioning

confidence: 99%

Gluten and the Gut: A Brief Review of Gluten-Related Gastrointestinal Disorders

Shah¹

2017

SOJI

View full text Add to dashboard Cite

show abstract

“…Nevertheless, translation into human studies has shown varying pathology, immunology and conflicting mucosal immunological events. [27][28][29][30] Interpreting and drawing definitive conclusions from the few clinical trials that focus on NCGS is difficult because of weaknesses in the study design or execution, for example inconsistent definition of NCGS and inclusion criteria, small number of participants, inclusion of participants with elevated markers of coeliac disease (intraepithelial lymphocytosis in the duodenum and evidence of immunological activation), or the non-distinction between gluten and other wheat components.…”

Section: The Current Evidence For Ncgsmentioning

confidence: 99%

Non‐coeliac gluten sensitivity: piecing the puzzle together

Biesiekierski

Iven

2015

UEG Journal

View full text Add to dashboard Cite

The avoidance of wheat-and gluten-containing products is a worldwide phenomenon. While coeliac disease is wellestablished, much remains unknown about whether gluten can be a trigger of gastrointestinal and/or extra-intestinal symptoms in patients without coeliac disease. In this article, we discuss the latest scientific evidence and our current understanding for the possible mechanisms of this largely ambiguous group, termed 'non-coeliac gluten sensitive' (NCGS). We can conclude that NCGS should be regarded as an independent disease outside of coeliac disease and wheat allergy, and that the number of patients affected is likely to be limited. Many questions remain unanswered and it needs to be verified whether the elimination of dietary gluten alone is sufficient for the control of symptoms, and to understand the overlap with other components of wheat.

show abstract

“…Recently, Brotveit et al [18] showed that NCGS patient had and increased density of intraepithelial CD3(?) T cells at baseline and a significant increase in interferon-c mRNA following gluten challenge suggesting that the adaptive immune system may play a role in NCGS.…”

Section: Pathogenesismentioning

confidence: 99%